tTG has been extensively studied in the years since and found to be one of the major autoantigens in celiac disease [3–7], to be necessary for the survival and growth of cancer cells [8–13], and to be important for the formation of protein aggregates that are characteristic of Alzheimer’s and Parkinson’s diseases [14–18]. Here, TGM2 is linked to celiac disease.